Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Temporary remote prescribing to end in March
The RCVS Standards Committee will continue to keep the position under review in light of any changes.
“We feel the time has come to revert to our usual guidance” – Melissa Donald, RCVS.

Temporary measures that allow veterinary surgeons to prescribe prescription-only veterinary medicines remotely will end on Monday, 14 March 2022, the RCVS has confirmed.

Remote prescribing was first introduced in spring 2020 to allow veterinary surgeons to make prescriptions without needing to physically examine the animal, subject to certain safeguards and conditions. 

The RCVS Standards Committee removed the dispensation in October 2021 but reinstated it in December 2021 in light of stricter rules on isolation and the threat of the Omicron variant. 

At its meeting on Monday (7 February), the Committee discussed the ongoing challenges posed by COVID-19 and recognised that staff absences due to isolation requirements were still causing issues. However, given the relaxation of the work from home requirement and the relaxation of restrictions generally across the UK, the Committee felt it was time to end the dispensation. 

Committee chair, Melissa Donald commented: “The safety and wellbeing of veterinary professionals, as well as the health and welfare of the animals they care for, have remained uppermost in our minds when considering this temporary position on remote prescribing.

“We are pleased to have been able to support the professions through a very difficult time by introducing this dispensation, however, it was only ever a temporary measure and, given the relaxation of restrictions across the UK, we feel the time has come to revert to our usual guidance. 

“We will continue to keep the position under review in light of any changes, including governments’ advice and regulations, as we have throughout the pandemic.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.